STACEY LYTLE: Open Payments
NPI 1265989982 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,231 in 57 payments from 20 companies in 2025. Trend: 2023 $1,081 · 2024 $780 · 2025 $1,231
Food & beverage: $1,231
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $174 |
| Exeltis, USA Inc. | 1 | $121 |
| SHIELD THERAPEUTICS INC | 5 | $115 |
| PFIZER INC. | 6 | $103 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $78 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $77 |
| Corcept Therapeutics | 4 | $76 |
| Lilly USA, LLC | 3 | $69 |
| MILLICENT US INC | 3 | $56 |
| Hologic Sales and Service, LLC | 2 | $45 |
Products named: UBRELVY, TWIRLA, ACCRUFER, NURTEC ODT, TRINTELLIX, Korlym, MOUNJARO, Tirosint.
Industry payments across OK — which companies pay providers there.
